Literature DB >> 33389755

Chronic transplant glomerulopathy: New insights into pathogenesis.

Avantee Gokhale1,2, Jorge Chancay1, Ron Shapiro2, Parmjeet Randhawa3, Madhav C Menon1,2.   

Abstract

There have been recent significant advances in short-term outcomes in renal transplantation, however, long-term allograft survival remains a challenge. With reported incidences as high of 74.5% of chronic graft loss in patients with biopsies showing transplant glomerulopathy (TG), this syndrome represents an important factor for chronic allograft complications. In this review we show an overview of the novel mechanistic insights into pathogenesis of TG, as well as a brief description of the pathology, diagnosis and newer prognostic indices within TG diagnosis. These data raise intriguing roles for cell-mediated immunity and podocyte stress in TG as well as reinforce previous associations of TG with ABMR. We also delve into management strategies for TG and report the paucity of existing clinical trial data for this prevalent condition in renal transplants.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  allograft failure; proteinuria; transplant glomerulopathy

Mesh:

Year:  2021        PMID: 33389755      PMCID: PMC8281330          DOI: 10.1111/ctr.14214

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  64 in total

1.  Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

Authors:  Simone A Joosten; Mieneke G A van Dixhoorn; Maria C Borrias; Hallgrimur Benediktsson; Peter A van Veelen; Cees van Kooten; Leendert C Paul
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.

Authors:  Nancy L Reinsmoen; Chih-Hung Lai; Harald Heidecke; Mark Haas; Kai Cao; Geraldine Ong; Mehrnoush Naim; Qi Wang; James Mirocha; Joseph Kahwaji; Ashley A Vo; Stanley C Jordan; Duska Dragun
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

3.  Clinical and pathological analyses of transplant glomerulopathy cases.

Authors:  Tomokazu Shimizu; Hideki Ishida; Daisuke Toki; Taiji Nozaki; Kazuya Omoto; Kazunari Tanabe; Kazuho Honda; Junki Koike
Journal:  Nephrology (Carlton)       Date:  2014-06       Impact factor: 2.506

4.  Human renal allografts. Analysis of lesions in long-term survivors.

Authors:  G J Busch; E G Galvanek; E S Reynolds
Journal:  Hum Pathol       Date:  1971-06       Impact factor: 3.466

Review 5.  The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.

Authors:  Héloise Cardinal; Mélanie Dieudé; Marie-Josée Hébert
Journal:  J Am Soc Nephrol       Date:  2016-10-17       Impact factor: 10.121

6.  Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation.

Authors:  J M Gloor; F G Cosio; D J Rea; H M Wadei; J L Winters; S B Moore; S R DeGoey; D J Lager; J P Grande; M D Stegall
Journal:  Am J Transplant       Date:  2006-06-19       Impact factor: 8.086

7.  Glomerular C4d deposits can mark structural capillary wall remodelling in thrombotic microangiopathy and transplant glomerulopathy: C4d beyond active antibody-mediated injury: a retrospective study.

Authors:  Adil H Gasim; Jamie S Chua; Ron Wolterbeek; John Schmitz; Eric Weimer; Harsharan K Singh; Volker Nickeleit
Journal:  Transpl Int       Date:  2017-03-23       Impact factor: 3.782

8.  Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants.

Authors:  Adnan Sharif; Edward S Kraus; Andrea A Zachary; Bonnie E Lonze; Susanna M Nazarian; Dorry L Segev; Nada Alachkar; Lois J Arend; Serena M Bagnasco; Lorraine C Racusen; Robert A Montgomery
Journal:  Transplantation       Date:  2014-03-15       Impact factor: 4.939

9.  Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies.

Authors:  A Loupy; C Suberbielle-Boissel; G S Hill; C Lefaucheur; D Anglicheau; J Zuber; F Martinez; E Thervet; A Méjean; D Charron; J P Duong van Huyen; P Bruneval; C Legendre; D Nochy
Journal:  Am J Transplant       Date:  2009-09-22       Impact factor: 8.086

10.  Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies.

Authors:  M D Wavamunno; P J O'Connell; M Vitalone; C L-S Fung; R D M Allen; J R Chapman; B J Nankivell
Journal:  Am J Transplant       Date:  2007-10-06       Impact factor: 8.086

View more
  3 in total

1.  Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial.

Authors:  Katharina A Mayer; Klemens Budde; Philip F Halloran; Konstantin Doberer; Lionel Rostaing; Farsad Eskandary; Anna Christamentl; Markus Wahrmann; Heinz Regele; Sabine Schranz; Sarah Ely; Christa Firbas; Christian Schörgenhofer; Alexander Kainz; Alexandre Loupy; Stefan Härtle; Rainer Boxhammer; Bernd Jilma; Georg A Böhmig
Journal:  Trials       Date:  2022-04-08       Impact factor: 2.279

Review 2.  Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases.

Authors:  Xue Tong; Yanheng Qiao; Yuanjian Yang; Haizhao Liu; Zhiyong Cao; Bo Yang; Lijuan Wei; Hongtao Yang
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

3.  The Proteome of Antibody-Mediated Rejection: From Glomerulitis to Transplant Glomerulopathy.

Authors:  Bertrand Chauveau; Anne-Aurélie Raymond; Sylvaine Di Tommaso; Jonathan Visentin; Agathe Vermorel; Nathalie Dugot-Senant; Cyril Dourthe; Jean-William Dupuy; Julie Déchanet-Merville; Jean-Paul Duong Van Huyen; Marion Rabant; Lionel Couzi; Frédéric Saltel; Pierre Merville
Journal:  Biomedicines       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.